Induction of Cyclin E and Inhibition of DNA Synthesis by the Novel Acronycine Derivative S23906-1 Precede the Irreversible Arrest of Tumor Cells in S Phase Leading to Apoptosis
| Autor: | Michel H. J. Koch, Sylvie Michel, François Tillequin, Stéphanie Lambel, Alain Pierré, John A. Hickman, Bruno Pfeiffer, Ghanem Atassi, Valérie Pérez, Delphine Peyroulan, Stéphane Léonce |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Pharmacology
Programmed cell death Cyclin E DNA synthesis Acronine DNA damage Cyclin-dependent kinase 2 Antineoplastic Agents Apoptosis DNA Cell cycle Biology Flow Cytometry Molecular biology S Phase Bromodeoxyuridine Tumor Cells Cultured biology.protein Humans Molecular Medicine HT29 Cells Cell Division Cyclin |
| Zdroj: | Molecular Pharmacology. 60:1383-1391 |
| ISSN: | 1521-0111 0026-895X |
| Popis: | S23906-1 is a diester derivative of 1,2-dihydrobenzo[b]acronycine with an unknown mechanism of action. This cytotoxic compound was 20-fold more potent than acronycine in inhibiting the proliferation of six tumor cell lines. Using a clonogenic assay of cell survival, the HT29 human colon carcinoma cell line was 100-fold more sensitive to S23906-1 than acronycine. Cell cycle analysis, by flow cytometry, showed that S23906-1 induced a partially reversible arrest of HT29 cells in G2+M at 1 microM and below and an irreversible arrest in S phase at 2.5 microM and above. These cell cycle effects were followed by cell death through apoptosis, quantified by annexin-V labeling. Inhibition of DNA synthesis was observed by complete prevention of bromodeoxyuridine (BrdU) incorporation after only 4 h of incubation with 5 microM S23906-1. Interestingly, under the same experimental conditions, a significant increase of cyclin E protein level was observed without any modification of cyclins D1, D2, D3, or A. This overexpressed cyclin E protein was not complexed with Cdk2, as shown by western blotting for Cdk2 in immunoprecipitates of cyclin E. Similar inhibition of BrdU incorporation and elevation of cyclin E protein were observed after treatment with cytosine arabinoside, which reversibly inhibited progression into S phase, but not after DNA damage induced by cisplatin. S23906-1 thus has a novel mechanism of action. A cell line resistant to S23906-1 showed that overexpression of cyclin E was implicated in the novel cytotoxic activity of this compound. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|